Sozener, C. Z. Et Al. 2019. Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases. Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Lisbon, Portugal), 450.

Sozener, C. Z., Gorgulu, B., Mungan, D., Sin, B. A., Misirligil, Z., Aydin, O., ... BAVBEK, S.(2019). Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases . Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.450). Lisbon, Portugal

Sozener, ZEYNEP Et Al. "Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases," Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 2019

Sozener, ZEYNEP Ç. Et Al. "Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Lisbon, Portugal, pp.450, 2019

Sozener, C. Z. Et Al. (2019) . "Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases." Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Lisbon, Portugal, p.450.

@conferencepaper{conferencepaper, author={ZEYNEP ÇELEBİ SÖZENER Et Al. }, title={Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): Single-center experience in 18 cases}, congress name={Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Lisbon}, country={Portugal}, year={2019}, pages={450} }